Summit Therapeutics Raises $500 Million in Private Placement to Propel Ivonescimab’s Clinical Advancement and Solidify Leadership in Next-Gen Oncology

In a significant capital infusion, Summit Therapeutics Inc., a Miami-headquartered biopharmaceutical company specializing in oncology, has successfully raised $500 million through a private placement of approximately 26.68 million common shares priced at $18.74 each—the closing price on October 21, 2025. The offering was led by a blend of institutional biotech investors and company insiders, signaling…

Read More

$17.25 Million Boost for VitriVax Signals a Shift in How Vaccines Could Reach the Unreached

When biotech firm VitriVax raised $17.25 million in a Series B funding round, co-led by Adjuvant Capital and RA Capital Management, LP, it revealed more than just money changing hands—it spotlighted a broader fracture point in global immunisation strategy. Based in Boulder, Colorado, VitriVax is tackling two fundamental hurdles in vaccine delivery: the cold-chain barrier and the logistical burden…

Read More

Uniphore Raises $260 Million in Landmark Series F Round Backed by NVIDIA, AMD, Snowflake, and Databricks — Cementing Its Position as the New Operating System for Enterprise AI

In a move that emphatically underlines the growing importance of enterprise-grade artificial intelligence, Uniphore has secured a $260 million Series F funding round, led by a roster of tech heavyweights including NVIDIA, AMD, Snowflake and Databricks, alongside prominent financial and sovereign investors such as NEA, March Capital, BNF Capital, National Grid Partners and Prosperity7 Ventures….

Read More

$375 Million Strategic Injected to Fuel Avride’s Autonomous Drive from Delivery Robots to Robotaxis

Headquartered in Austin, Texas, Avride has secured a transformative strategic commitment of up to $375 million from lead backers Uber Technologies, Inc. and Nebius Group N.V. to accelerate its shift from sidewalk-delivery robots toward fully autonomous ride-hailing services. The agreement builds on an existing multi-year commercial partnership and sets a bold target: launch of Avride’s…

Read More

From Graphite to Silicon: How Coreshell’s $1 M Win at Startup World Cup 2025 May Shift the EV Battery Landscape

The global spotlight turned to San Francisco on October 17, 2025, as ten startup finalists—filtered from thousands across dozens of countries—pitched before a sharp-eyed panel of Silicon Valley investors. At the heart of the debate: who would claim the coveted $1 million investment prize at the grand finale of the Startup World Cup 2025, organised…

Read More

The Students Who Nearly Missed Out—GradBridge’s $20M Raise Could Change That

In a student loan market saturated with first-pass credit decisions and rigid underwriting, one fintech startup is betting on those who fall through the cracks. GradBridge, a Delaware-based student lending company, has raised $20 million in Series A funding to support the launch of its unique “second-look” private student loan product—aimed squarely at students who’ve…

Read More

Redefining Immune Therapy: Electra Therapeutics Raises $183 Million to Battle Deadly Hyperinflammation and Cancer

In the complex world of immune-mediated diseases, where treatment options often fall short, Electra Therapeutics is carving a distinct path. The late-stage biotech, based in the U.S., has secured a robust $183 million in Series C funding to advance its groundbreaking precision therapies targeting severe immunological conditions and hematologic cancers. The financing round, co-led by…

Read More

ShopMy Raises $70 Million at $1.5 Billion Valuation, Redefining Commerce Through Taste-Driven Curation

In a fresh chapter for creator-driven commerce, ShopMy, the curated commerce infrastructure company, has secured $70 million in a funding round led by Avenir, bringing its valuation to $1.5 billion. This capital injection, bolstered by heavyweight investors including Bain Capital Ventures, Bessemer Venture Partners, Menlo Ventures, and notable individual backers like Sofia Richie and Aimee…

Read More

Ampa Raises $8.5M to Take Portable Brain Stimulation Nationwide, Redefining Depression Treatment

In a pivotal moment for neurotechnology, Ampa—a Palo Alto‑based company—has emerged from stealth mode and announced a nationwide rollout of its portable brain‑stimulation platform. The company raised an oversubscribed US$8.5 million funding round, led by Nexus NeuroTech Ventures, with participation from Satori Capital, Morningside Ventures, Continuum Health Ventures, the Zabara Foundation and individual investors. The company’s flagship device—the…

Read More

Peregrine Energy Solutions Raises US$130 Million to Power the U.S. Grid’s Next Chapter

In a significant influx of capital, Peregrine Energy Solutions (headquartered in Boulder, Colorado) has secured US$130 million to accelerate its utility‑scale battery storage pipeline across the United States. The funding round draws on a diverse international consortium, including the Ministry of Environment, Republic of Korea, IMM Investment, Woori Private Equity Asset Management and investment funds managed…

Read More